Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,255 | 217,918 | 138,614 | 114,514 | 50,885 |
| Marketable Securities | 469,057 | 273,080 | 55,105 | 78,819 | 43,504 |
| Receivables | 10,899 | 4,121 | 4,861 | 2,395 | 3,918 |
| Inventories | 2,768 | 2,718 | 1,762 | 861 | 951 |
| Other current assets | 8,147 | 20,547 | 9,532 | 9,614 | 6,600 |
| TOTAL | $596,126 | $518,384 | $209,874 | $206,203 | $105,858 |
| Non-Current Assets | |||||
| PPE Net | 27,338 | 17,371 | 5,960 | 7,157 | 9,130 |
| Intangibles | 30,451 | 33,121 | 35,530 | 38,271 | 42,543 |
| Other Non-Current Assets | 3,269 | 3,900 | 7,494 | 4,276 | 8,842 |
| TOTAL | $61,058 | $54,392 | $48,984 | $49,704 | $60,515 |
| Total Assets | $657,184 | $572,776 | $258,858 | $255,907 | $166,373 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,270 | 2,065 | 7,238 | 7,514 | 7,835 |
| Accounts payable and accrued liabilities | 4,696 | 5,710 | 2,568 | 4,288 | 2,095 |
| Accrued Expenses | 19,474 | 16,392 | 13,971 | 12,293 | 12,349 |
| Other current liabilities | N/A | N/A | 6,893 | N/A | N/A |
| TOTAL | $111,444 | $124,699 | $62,205 | $25,139 | $23,793 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,478 | 9,938 | 362 | 7,822 | 14,915 |
| Deferred Revenues | 75,681 | 92,662 | 31,535 | 1,044 | 1,514 |
| Other Non-Current Liabilities | 129,494 | 122,727 | 195,657 | 154,339 | 125,000 |
| TOTAL | $243,675 | $300,697 | $195,781 | $162,205 | $139,915 |
| Total Liabilities | $355,119 | $425,396 | $257,986 | $187,344 | $163,708 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,064 | 97,595 | 92,943 | 82,485 | 72,480 |
| Common Shares | 99 | 97 | 87 | 82 | 72 |
| Retained earnings | -696,150 | -851,216 | -827,745 | -816,751 | -770,848 |
| Other shareholders' equity | 12,496 | 38,138 | 538 | 4,278 | 3,178 |
| TOTAL | $302,065 | $147,380 | $872 | $68,563 | $2,665 |
| Total Liabilities And Equity | $657,184 | $572,776 | $258,858 | $255,907 | $166,373 |